Ntn1 (Netrin-1) controls Par complex localisation during axon guidance29, and Spry2 (Sprouty2) is a modulator of tyrosine receptor kinase signalling that was previously shown to repress the polarised epithelial phenotype of cancer cells30. The gene discussed is SPRY2; the disease is cancer.